A improving adherence to treatment – metformin XR

Czech version

Published in: Diab Obez 2021; 21(41): 49-50
Category:

Sources

Davies MJ, D‘Alessio DA, Fradkin J et al. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2018; 61(12): 2461–2498. Dostupné z DOI: <http://dx.doi.org/10.1007/s00125–018–4729–5>.
Buse JB, Wexler DJ, Tsapas A et al. 2019 update to: Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2020; 43(2): 487–493. Dostupné z DOI: <http://dx.doi.org/10.2337/dci19–0066>. Erratum in Erratum Diabetes Care 2020; 43(7): 1670. Dostupné z DOI: <http://dx.doi.orh/10.2337/dc20-er07>.
Schroner, Z, Uličianky V. Metformín – súčasné postavenie v liečbe diabetes mellitus 2. typu a diskutované otázky ohľadom jeho použitia. Via Pract 2015; 12(4): 152–156.
McCreight LJ, Bailey CJ, Pearson JR. Metformin and gastrointestinal tract. Diabetologia 2016; 59(3),:426–435. Dostupné z DOI: <http://dx.doi.org/10.1007/s00125–015–3844–9>.
Cubbedu LX, Bonisch H, Gothert M et al. Effects of metformin on intestinal 5-hydroxytryptamine (5-HT) release and on 5-HT 3 receptors. Naunyn Schmiedebergs Arch Pharmacol 2000; 361(1): 85–91. Dostupné z DOI: <http://dx.doi.org/10.1007/s002109900152>.
Donelly LA, Morris AD, Pearson ER et al. Adherence in patients transferred from immediate release metformin to a sustained release formulation: a population-based study. Diabetes Obes Metab 2009; 11(4): 338–342. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1463–1326.2008.00973.x>.
Levy J, Cobas RA, Gomes MB. Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus. Diabetol Metab Syndr 2010; 2: 16–22. Dostupné z DOI: <http://dx.doi.org/10.1186/1758–5996–2-16>.
Karen I, Svačina Š, Lžičarová B et al. Bezpečnostný profil XR formy metformínu v porovnání se standardní formou u pacientu s diabetes mellitus. 2. typu v ČR. Practicus 2013; 12(2): 18–24. Dostupné z WWW: <https://ceeor.com/storage/app/media/Publications/Research/Metforminy.pdf>.